Dow Up 0.07% Nasdaq Up 0.61%

Celgene Corporation (CELG)

-NasdaqGS
112.61 Up 1.54(1.39%) Nov 26, 4:00PM EST
|After Hours : 112.78 Up 0.17 (0.15%) Nov 26, 6:18PM EST
Prev Close:111.07
Open:111.46
Bid:111.50 x 100
Ask:N/A
1y Target Est:112.09
Beta:2.02
Next Earnings Date:29-Jan-15CELG Earnings announcement
Day's Range:109.20 - 112.82
52wk Range:66.85 - 112.82
Volume:3,269,769
Avg Vol (3m):4,883,330
Market Cap:89.94B
P/E (ttm):58.99
EPS (ttm):1.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGUp 1.39%89.94B
JNJUp 0.48%300.09B

Key Statistics

Forward P/E (1 yr):23.12
P/S (ttm):12.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback